ERBB2 and neoplasm: Several clinical trials reported that GBM TAAs, including MAGE-1, HER-2, gp100, AIM-2, TRP-2, EphA2,105 survivin50, IL13Rα2,58 and heat-shock peptide protein complex-96 (HSPPC-96),106,107 possess favourable anti-tumour potency51, 52, 53 (Table 1).